M.I.TECH Co.,Ltd (KOSDAQ:179290)

Market Cap	146.78B -44.4%
Revenue (ttm)	66.63B +83.1%
Net Income	19.36B +246.9%
EPS	598.19 +227.9%
Shares Out	32.37M
PE Ratio	7.58
Forward PE	n/a
Dividend	100.00 (2.16%)
Ex-Dividend Date	Dec 29, 2025

Volume	48,934
Open	4,635.00
Previous Close	4,635.00
Day's Range	4,480.00 - 4,670.00
52-Week Range	4,345.00 - 8,340.00
Beta	-0.12
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About M.I.TECH Co.,Ltd

M.I.TECH Co.,Ltd engages in the provision of various medical devices in South Korea. The company offers HANAROSTENT, a non-vascular stent; and glucometers under the GBIO BASE and RAPICHECK brand names. It also provides beauty systems, such as BRT system which is used in cleansing skin and inject the effective component in non-invasive way; and ClearView which is used in injecting the effective component in non-invasive way and instantly check skin condition before and after treatment. The company was formerly known as Solco Intermed Co., Ltd. a...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1991
• Employees: 166
• Stock Exchange: KOSDAQ
• Ticker Symbol: 179290

Financial Performance

In 2025, M.I.TECH Co.,Ltd's revenue was 67.15 billion, an increase of 24.93% compared to the previous year's 53.75 billion. Earnings were 20.33 billion, an increase of 11.18%.